(19)
(11) EP 2 265 616 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.01.2014 Bulletin 2014/02

(45) Mention of the grant of the patent:
20.11.2013 Bulletin 2013/47

(21) Application number: 09709265.4

(22) Date of filing: 06.02.2009
(51) International Patent Classification (IPC): 
C07D 491/048(2006.01)
A61P 35/00(2006.01)
 A61K 31/4355(2006.01)
(86) International application number:
PCT/US2009/033311
(87) International publication number:
WO 2009/100282 (13.08.2009 Gazette 2009/33)

(54)

FURO-AND THIENO[3,2-C]PYRIDINES

FURO- UND THIENO[3,2-C]PYRIDINE

FURO-ET THIENO[3,2-C]PYRIDINES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 06.02.2008 US 63800 P
03.12.2008 US 119553 P

(43) Date of publication of application:
29.12.2010 Bulletin 2010/52

(73) Proprietor: OSI Pharmaceuticals, LLC
Farmingdale, NY 11735 (US)

(72) Inventors:
  • MULVIHILL, Mark, J.
    Farmingdale, NY 11735 (US)
  • WANG, Jing
    Farmingdale, NY 11735 (US)
  • CHEN, Xin
    Farmingdale, NY 11735 (US)
  • WANG, Ti
    Farmingdale, NY 11735 (US)
  • LI, An-hu
    Farmingdale, NY 11735 (US)
  • STEINIG, Arno, G.
    Farmingdale, NY 11735 (US)
  • KLEINBERG, Andrew
    Farmingdale, NY 11735 (US)
  • WENG, Qinghua
    Farmingdale, NY 11735 (US)
  • DONG, Hanqing
    Farmingdale, NY 11735 (US)
  • JIN, Meizhong
    Farmingdale, NY 11735 (US)

(74) Representative: Mintz Levin Cohn Ferris Glovsky and Popeo LLP 
Alder Castle 10 Noble Street
London EC2V 7JX
London EC2V 7JX (GB)


(56) References cited: : 
WO-A-03/059913
WO-A-2007/124181
 WO-A-2007/027855
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).